Participants 0 69 4
Pentraxin-3 in chronic heart failure: the CORONA and GISSI-HF trials.
Participants 358 399 6
two large populations of patients with HF
Participants 421 656 9
Plasma levels of PTX3 were measured at randomization and after 3 months in 1457 patients enrolled in the Controlled Rosuvastatin Multinational Trial in HF (CORONA) and 1233 patients enrolled in the GISSI-Heart Failure trial (GISSI-HF).
Participants 1715 1739 4
patients with chronic HF
